CN Patent

CN1946353B — 纳曲酮长效制剂和使用方法

Assigned to Alkermes Pharma Ireland Ltd · Expires 2013-06-05 · 13y expired

What this patent protects

这里进行描述的本发明起于纳曲酮长效制剂临床试验期间的意外发现。同样，本发明包含了需要纳曲酮对个体进行治疗的方法，该方法包括进行包括纳曲酮的长效制剂的肠胃外给药步骤和在这种方法中使用的药剂生产中纳曲酮的使用。

USPTO Abstract

这里进行描述的本发明起于纳曲酮长效制剂临床试验期间的意外发现。同样，本发明包含了需要纳曲酮对个体进行治疗的方法，该方法包括进行包括纳曲酮的长效制剂的肠胃外给药步骤和在这种方法中使用的药剂生产中纳曲酮的使用。

Drugs covered by this patent

Patent Metadata

Patent number
CN1946353B
Jurisdiction
CN
Classification
—
Expires
2013-06-05
Drug substance claim
No
Drug product claim
No
Assignee
Alkermes Pharma Ireland Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.